跳至主要内容
临床试验/CTRI/2023/03/050882
CTRI/2023/03/050882尚未招募Unknown

Effect Of Methotrexate Versus Methotrexate And Apremilast On Parameters Of Metabolic Syndrome In Patients Of Chronic Plaque Psoriasis: An Observational Study.

Anisha Biswal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. All Psoriasis patients >18 years of age
  • 2. PASI >10 and or DLQI >10

排除标准

  • 1.Contraindications to use of any drug methotrexate or apremilast.
  • 2.Patient known case of diabetes mellitus, hypertension, dyslipidemia
  • 3. Patient on any other disease modifying drugs in last 6weeks.
  • 4. Patient on any drugs confounding any metabolic parameters like hypolipidemic drugs, anti-diabetic drugs, oral contraceptives, antihypertensive drugs, acitretin, orlistat.

研究者

发起方
Anisha Biswal

相似试验